Beijing SH biotechnology Co., Ltd. and Beijing Hunkan biological Co., Ltd. signed a strategic cooperation agreement

Time:2018-10-17 Author:

Beijing SH biotechnology Co., Ltd. and Beijing Hunkan biotechnology Co., Ltd. hold talks and sign a strategic cooperation agreement in Beijing, Oct. 11, 2018. The two sides have officially become cooperative partners to promote the development and innovation of stem cell therapy industry through the integration of technological and resource advantages.
 
Beijing Huakan biotechnology Co., Ltd. is committed to tissue engineering, biomaterials, cell biology and regenerative medicine cross frontier disciplines, the development and transformation of the micro processing technology, automatic three-dimensional scale expansion micro tissue culture system and new type of stem cell therapy, and other fields has a number of independent intellectual property rights. Its core technology is derived from the eight-year research and development achievements of School of Medicine, Tsinghua University, and related products and services have been successfully put on the market.
 
Through this strategic cooperation, SH biotechnology will further improve the efficacy of stem cell disease treatment and promote the industrialization of stem cell development. Based on its core technology of tissue engineering and the scientific research strength of Tsinghua university, niches will provide customized tissue engineering products and innovative treatment solutions for the field of stem cell therapy, and the two sides will jointly create a new generation of stem cell treatment products. Yu hongli, CEO of Beijing SH biotechnology and Dr. Liu wei, CEO of Beijing Huakan biotechnology attended the signing ceremony and completed the signing. During the signing ceremony, the two teams had an in-depth exchange of views. Academician Wu zuze of the academy of military medical sciences and professor Du yanan of tsinghua university witnessed the signing ceremony and highly affirmed the prospect of cooperation between the two sides. Also present at the signing ceremony were Wang biao, assistant President of Tsinghua holding Co., Ltd. and Xu zeli, senior manager of technology transfer, Dr. Sun yanjun, CTO of SH biotechnology Co., Ltd., and Dr. Yan yan, CTO of yanxiaojun biological Co., Ltd.